To elucidate the clinical features and diagnostic challenges of the co-occurrence of connective tissue disease (CTD), chronic myelomonocytic leukemia (CMML), and myelofibrosis (MF), and to highlight the therapeutic significance of a dual-target treatment strategy, particularly in improving patient outcomes.
Key Findings:
The patient initially presented with symptoms suggestive of CTD but was later diagnosed with CMML and advanced MF after extensive evaluation.
The dual-target treatment led to significant improvement in systemic symptoms, monocytosis, anemia, and thrombocytopenia, demonstrating the effectiveness of this approach.
Interpretation:
The case illustrates the complexity of diagnosing and managing patients with overlapping autoimmune and hematologic disorders, emphasizing the need for careful evaluation to avoid misdiagnosis and improve treatment outcomes.
Limitations:
The case report is based on a single patient, limiting the generalizability of findings and introducing potential biases.
Lack of comprehensive cytogenetic and molecular analyses during earlier evaluations may have impacted the diagnostic process.
Conclusion:
This case highlights the importance of recognizing the interplay between autoimmune diseases and hematologic malignancies, advocating for a tailored therapeutic approach and interdisciplinary collaboration to improve patient outcomes.
